Edwards Lifesciences Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Edwards Lifesciences ha un patrimonio netto totale di $9.6B e un debito totale di $597.5M, che porta il suo rapporto debito/patrimonio netto a 6.2%. Le sue attività totali e le sue passività totali sono rispettivamente $13.0B e $3.4B. L'EBIT di Edwards Lifesciences è $1.9B rendendo il suo rapporto di copertura degli interessi -28.5. Ha liquidità e investimenti a breve termine pari a $4.4B.
Informazioni chiave
6.2%
Rapporto debito/patrimonio netto
US$597.50m
Debito
| Indice di copertura degli interessi | -28.5x |
| Contanti | US$4.45b |
| Patrimonio netto | US$9.61b |
| Totale passività | US$3.36b |
| Totale attività | US$12.97b |
Aggiornamenti recenti sulla salute finanziaria
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Recent updates
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 11Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
Oct 25Bearish: Analysts Just Cut Their Edwards Lifesciences Corporation (NYSE:EW) Revenue and EPS estimates
Sep 11Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $6.7B ) di EW superano le sue passività a breve termine ( $1.9B ).
Passività a lungo termine: Le attività a breve termine di EW ( $6.7B ) superano le sue passività a lungo termine ( $1.4B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: EW ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di EW si è ridotto da 15.6% a 6.2% negli ultimi 5 anni.
Copertura del debito: Il debito di EW è ben coperto dal flusso di cassa operativo ( 135% ).
Copertura degli interessi: EW matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.